The biological consequences of a constitutively active ERα, driving cancer cell proliferation and ERα target gene expression, have been functionally tested and confirmed using ectopic expression and CRISPR-Cas9-edited models, showing they share their genetic drivers with cells with the wildtype (WT) ERα [10,11,12,13,14,15]. Here, ESR1 is linked to cancer.